Bringing Together Innovators, Leading Investors and Major Healthcare Corporations

The 24th MedTech Investing Europe Conference will be held on 5-6 April 2017 in Lausanne, Switzerland. We will be welcoming over 130 attendees and showcasing an unrivalled roster of venture-stage life science companies.

Our programme will include a mix of leading investors and healthcare industry specialists with a range of topical debates, from a look at how healthcare economics plays out in the real world to a 360 look at exits.

Our investor community includes single family office and private multi-family offices worth at least €100 million as well as some of the most pro-active VC, angel and corporate investors. Financiers will be attending from 4 continents and represent some of the most active and innovative investors in the sector.


Fountain Healthcare Partners

Investment Manager
Creathor Venture

CM-CIC Innovation

Fisher Broyles

Albion Technology & General VCT

Isocell Laboratories

Managing General Partner
Boston Millennia Partners


Senior Investment Director
Endeavour Vision

Wellington Partners

General Partner
Flare Capital Partners

Lion’s Head Global Partners

General Partner
VI Partners AG

CEO & Managing Partner

Managing Partner
Imperial Innovations


Senior Managing Director
OrbiMed Healthcare Fund Management

Omega Funds

Presenting Companies

Over the last 23 events we have showcased over 830 early- to mid-stage life science companies to our unrivalled audience of investors. Representing all areas of life sciences our presenting companies originate from over 30 countries and are at a range of different stages from pre-clinical to commercialisation. Just some of the previous companies include:







Registration, refreshments and networking
08:40 - 09:40
Welcome from the State of Vaud
09:20 - 09:40
Chairman’s Opening Remarks – Resilience in MedTech
09:40 - 10:00

In the healthcare landscape, old and new players rub shoulders in a world of exciting innovations including nanotechnology, AI and robotics. Many bumps in the road remain though. Regulatory burdens and reimbursement pressures add to the complexities of scaling and development. For investors, longer and more twisted routes to exit exist, hindering entrepreneurs and restricting investment at key stages. But the life science industry is resilient and there are plenty of reasons to be positive with political change and technological disruption likely to keep the market fast moving.

Benoit Dubuis. President. BioAlps.
Financing MedTech – Investor Panel
10:10 - 11:10

From early-stage founders looking to kick-start their journey to later-stage companies aiming to carry on as independent organisations, finding the right finance from the right people is vital. How can companies maximise their chances of success and how will strategic plans that understands growth, the customer-base and where an acquisition may be likely smooth the way?

  • What are the investment trends of 2017?
  • Rules of Attraction – what does a great investment look like?
  • Perfect fit – corporate investors, crowd-funding and family office finance
  • How much support do teams need to think strategically about investment?
Mary Anne Cordeiro. Director. Albion Technology & General VCT.
Nissim Darvish. Senior Managing Director. OrbiMed Healthcare Fund Management.
Katie Ellias. Senior Investment Director . Endeavour Vision.
Florentine Radelfahr. Associate. Wellington Partners.
Christian Leikert. Investment Manager. Creathor Venture.
Karine Lignel. CEO. CM-CIC Innovation.
Morning coffee and networking opportunity
11:10 - 11:30
MedTech companies pitch their investment opportunities
11:30 - 12:30
How does Healthcare Economics playout in the real world?
12:30 - 13:30

Economic as well as clinical benefit is a key consideration for new innovations in MedTech and new products will be scrutinized by investors and customers alike and are expected to measure up. But what does this mean in practical terms for an early-stage company and how are investors reacting to this changing environment?

  • Health economic analysis and competitive advantage
  • How is this shift shaping investment choices?
  • How is economic benefit bringing in new investors?
  • How does healthcare economics fit with other new trends in life sciences?
Samuel Shafner. Partner. Fisher Broyles.
Michael Greeley. General Partner. Flare Capital Partners.
Dana Callow. Managing General Partner. Boston Millennia Partners.
Lunch and networking opportunity
13:30 - 14:15
MedTech companies pitch their investment opportunities
14:15 - 15:10
The Challenges of Commercialisation
15:10 - 16:10

Whilst there is a steady flow of early-stage entrepreneurship and visionary innovators, it is within the commercialisation stage that many companies face multiple challenges. How do company owners balance the demands of tech transfer, intellectual property protection and licensing? What time does this leave for incubating a company and seeking funding in a competitive environment?

  • Incubators and partnerships
  • Ideas into practice – tips for success
  • Finding growth funding – practical tips
  • How can you de-risk in this difficult stage?
Dani Bach. Managing Partner. Imperial Innovations.
Afternoon coffee and networking opportunity
16:10 - 16:30
One-To-One Meetings
16:30 - 17:50

Special pre-scheduled individual One-To-One meetings  will be taking place in our dedicated meeting area. This session will consist of 4 x 20min One-To-One meetings.

Networking Drinks Reception
18:00 - 19:00


Sponsors of the MTI events represent leading companies and organisations providing services to early to mid-stage life science companies, investors and major healthcare corporations. Sponsors receive unrivalled exposure and access to some of the smartest start-ups and active family offices.

To enquire about sponsorship opportunities at upcoming MTI events, please contact Peter Newton, or +44(0)203 763 2800.

We are proud to be working with the following sponsors for the 24th MedTech Investing Europe Conference, 5-6 April 2017 in Lausanne, Switzerland:


 5 - 6 
ROYAL SAVOY HOTEL, Lausanne, Switzerland
View map

Contact us

Where to find us

Campden Wealth 30 Cannon Street London EC4M 6XH, United Kingdom

Get in touch